Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Announcement | 17 July 2026

StockFin.ai

Try Free

📢 Key Event
Company completes acquisition of 85% stake in Aequitas Healthcare.

Jagsonpal Pharmaceuticals announced completion of its acquisition of an 85% equity stake in Aequitas Healthcare Private Limited, finalizing a deal previously disclosed on June 29 and updated on July 7 and 8, 2026, marking a strategic expansion into healthcare services.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How will the Aequitas acquisition impact Jagsonpal's profitability?" "What is the purchase price and financing structure?" "How does this affect Jagsonpal's dividend policy?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 17 July 2026

WIPRO Wipro Limited Financial Results TATAELXSI Tata Elxsi Limited Financial Results TATATECH Tata Technologies Limited Financial Results JAYNECOIND Jayaswal Neco Industries Limited Financial Results FEDERALBNK The Federal Bank Limited Corporate Action UYFINCORP U. Y. Fincorp Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day